More than one billion doses of coronavirus vaccines have been administered worldwide, less than five months after the first mass inoculation programs began to be rolled out, according to an AFP tally on Saturday.
At least 1,002,938,540 doses have been administered in 207 countries and territories, according to the tally compiled from official sources.
More than half, or 58 percent, have been given in three countries: the United States with 225.6 million doses, China with 216.1 million doses and India with 138.4 million.
However, in terms of the proportion of the population who have been vaccinated, Israel is in the lead, with nearly six out of every 10 Israelis fully inoculated.
That is followed by the United Arab Emirates where more than 51% of the population has received at least one shot, Britain with 49%, the US with 42%, Chile with 41%, Bahrain with 38%and Uruguay with 32%.
In the EU, 128 million doses have been administered to 21% of the population. Malta is leading the way in the 27-nation bloc, with 47% of its population inoculated and Hungary with 37%. But in Germany, only 22.6% of the population have been vaccinated, 22.3% in Spain, 20.5% in France and 19.9% in Italy.
Worldwide, the number of vaccine doses administered has doubled in less than a month as inoculation programs pick up speed.
While the majority of poor countries have also started to vaccinate, mainly thanks to the Covax program, inoculation is still largely a privilege of high-income countries, as defined by the World Bank, which are home to 16 percent of the world’s population but have administered 47% of vaccine doses.
Low-income countries account for just 0.2% of doses administered.
Some 12 countries have still to begin vaccinating — seven in Africa (Tanzania, Madagascar, Burkina Faso, Chad, Burundi, Central African Republic and Eritrea; three in Oceania (Vanuatu, Samoa and Kiribati; one in Asia (North Korea); and one in the Caribbean (Haiti).
Despite the trouble that has plagued it since it was approved for use, the jab developed by AstraZeneca and Oxford University is the most widely used so far, and has been administered in three-quarters or 156 of those countries and territories that have started vaccinating.
A rival jab developed by Pfizer and BioNTech has been administered in 91 countries, or 44% of the total. Another shot developed by Moderna has been administered in 46 countries or 22%. Sinopharm’s jab has been administered in at least 41 countries or 20% of the total, Sputnik V in at least 32 countries or 15%, and Sinovac in at least 21 or 10%.